The global Minimal Residual Disease (MRD) Dynamic Monitor market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
The 鈥淢inimal Residual Disease (MRD) Dynamic Monitor Industry Forecast鈥� looks at past sales and reviews total world Minimal Residual Disease (MRD) Dynamic Monitor sales in 2024, providing a comprehensive analysis by region and market sector of projected Minimal Residual Disease (MRD) Dynamic Monitor sales for 2025 through 2031. With Minimal Residual Disease (MRD) Dynamic Monitor sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Minimal Residual Disease (MRD) Dynamic Monitor industry.
This Insight Report provides a comprehensive analysis of the global Minimal Residual Disease (MRD) Dynamic Monitor landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Minimal Residual Disease (MRD) Dynamic Monitor portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Minimal Residual Disease (MRD) Dynamic Monitor market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Minimal Residual Disease (MRD) Dynamic Monitor and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Minimal Residual Disease (MRD) Dynamic Monitor.
This report presents a comprehensive overview, market shares, and growth opportunities of Minimal Residual Disease (MRD) Dynamic Monitor market by product type, application, key players and key regions and countries.
Segmentation by Type:
Blood Tumor MRD Dynamic Monitor
Solid Ttumor MRD Dynamic Monitor
Segmentation by Application:
Adjuvant Therapy Testing
Prognostic Assessment
Postoperative Recurrence Detection
Immunotherapy Efficacy Testing
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
BGI Genomics Co.,Ltd.
OrigiMed
Burning Rock Biotech
Predicine
Genecast
3D Medicines
Gene+
Geneseeq
Tongshu Biotechnology
Berry Oncology
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Minimal Residual Disease (MRD) Dynamic Monitor 麻豆原创 Size (2020-2031)
2.1.2 Minimal Residual Disease (MRD) Dynamic Monitor 麻豆原创 Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Minimal Residual Disease (MRD) Dynamic Monitor by Country/Region (2020, 2024 & 2031)
2.2 Minimal Residual Disease (MRD) Dynamic Monitor Segment by Type
2.2.1 Blood Tumor MRD Dynamic Monitor
2.2.2 Solid Ttumor MRD Dynamic Monitor
2.3 Minimal Residual Disease (MRD) Dynamic Monitor 麻豆原创 Size by Type
2.3.1 Minimal Residual Disease (MRD) Dynamic Monitor 麻豆原创 Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Minimal Residual Disease (MRD) Dynamic Monitor 麻豆原创 Size 麻豆原创 Share by Type (2020-2025)
2.4 Minimal Residual Disease (MRD) Dynamic Monitor Segment by Application
2.4.1 Adjuvant Therapy Testing
2.4.2 Prognostic Assessment
2.4.3 Postoperative Recurrence Detection
2.4.4 Immunotherapy Efficacy Testing
2.4.5 Others
2.5 Minimal Residual Disease (MRD) Dynamic Monitor 麻豆原创 Size by Application
2.5.1 Minimal Residual Disease (MRD) Dynamic Monitor 麻豆原创 Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Minimal Residual Disease (MRD) Dynamic Monitor 麻豆原创 Size 麻豆原创 Share by Application (2020-2025)
3 Minimal Residual Disease (MRD) Dynamic Monitor 麻豆原创 Size by Player
3.1 Minimal Residual Disease (MRD) Dynamic Monitor 麻豆原创 Size 麻豆原创 Share by Player
3.1.1 Global Minimal Residual Disease (MRD) Dynamic Monitor Revenue by Player (2020-2025)
3.1.2 Global Minimal Residual Disease (MRD) Dynamic Monitor Revenue 麻豆原创 Share by Player (2020-2025)
3.2 Global Minimal Residual Disease (MRD) Dynamic Monitor Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Minimal Residual Disease (MRD) Dynamic Monitor by Region
4.1 Minimal Residual Disease (MRD) Dynamic Monitor 麻豆原创 Size by Region (2020-2025)
4.2 Global Minimal Residual Disease (MRD) Dynamic Monitor Annual Revenue by Country/Region (2020-2025)
4.3 Americas Minimal Residual Disease (MRD) Dynamic Monitor 麻豆原创 Size Growth (2020-2025)
4.4 APAC Minimal Residual Disease (MRD) Dynamic Monitor 麻豆原创 Size Growth (2020-2025)
4.5 Europe Minimal Residual Disease (MRD) Dynamic Monitor 麻豆原创 Size Growth (2020-2025)
4.6 Middle East & Africa Minimal Residual Disease (MRD) Dynamic Monitor 麻豆原创 Size Growth (2020-2025)
5 Americas
5.1 Americas Minimal Residual Disease (MRD) Dynamic Monitor 麻豆原创 Size by Country (2020-2025)
5.2 Americas Minimal Residual Disease (MRD) Dynamic Monitor 麻豆原创 Size by Type (2020-2025)
5.3 Americas Minimal Residual Disease (MRD) Dynamic Monitor 麻豆原创 Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Minimal Residual Disease (MRD) Dynamic Monitor 麻豆原创 Size by Region (2020-2025)
6.2 APAC Minimal Residual Disease (MRD) Dynamic Monitor 麻豆原创 Size by Type (2020-2025)
6.3 APAC Minimal Residual Disease (MRD) Dynamic Monitor 麻豆原创 Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Minimal Residual Disease (MRD) Dynamic Monitor 麻豆原创 Size by Country (2020-2025)
7.2 Europe Minimal Residual Disease (MRD) Dynamic Monitor 麻豆原创 Size by Type (2020-2025)
7.3 Europe Minimal Residual Disease (MRD) Dynamic Monitor 麻豆原创 Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Minimal Residual Disease (MRD) Dynamic Monitor by Region (2020-2025)
8.2 Middle East & Africa Minimal Residual Disease (MRD) Dynamic Monitor 麻豆原创 Size by Type (2020-2025)
8.3 Middle East & Africa Minimal Residual Disease (MRD) Dynamic Monitor 麻豆原创 Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Minimal Residual Disease (MRD) Dynamic Monitor 麻豆原创 Forecast
10.1 Global Minimal Residual Disease (MRD) Dynamic Monitor Forecast by Region (2026-2031)
10.1.1 Global Minimal Residual Disease (MRD) Dynamic Monitor Forecast by Region (2026-2031)
10.1.2 Americas Minimal Residual Disease (MRD) Dynamic Monitor Forecast
10.1.3 APAC Minimal Residual Disease (MRD) Dynamic Monitor Forecast
10.1.4 Europe Minimal Residual Disease (MRD) Dynamic Monitor Forecast
10.1.5 Middle East & Africa Minimal Residual Disease (MRD) Dynamic Monitor Forecast
10.2 Americas Minimal Residual Disease (MRD) Dynamic Monitor Forecast by Country (2026-2031)
10.2.1 United States 麻豆原创 Minimal Residual Disease (MRD) Dynamic Monitor Forecast
10.2.2 Canada 麻豆原创 Minimal Residual Disease (MRD) Dynamic Monitor Forecast
10.2.3 Mexico 麻豆原创 Minimal Residual Disease (MRD) Dynamic Monitor Forecast
10.2.4 Brazil 麻豆原创 Minimal Residual Disease (MRD) Dynamic Monitor Forecast
10.3 APAC Minimal Residual Disease (MRD) Dynamic Monitor Forecast by Region (2026-2031)
10.3.1 China Minimal Residual Disease (MRD) Dynamic Monitor 麻豆原创 Forecast
10.3.2 Japan 麻豆原创 Minimal Residual Disease (MRD) Dynamic Monitor Forecast
10.3.3 Korea 麻豆原创 Minimal Residual Disease (MRD) Dynamic Monitor Forecast
10.3.4 Southeast Asia 麻豆原创 Minimal Residual Disease (MRD) Dynamic Monitor Forecast
10.3.5 India 麻豆原创 Minimal Residual Disease (MRD) Dynamic Monitor Forecast
10.3.6 Australia 麻豆原创 Minimal Residual Disease (MRD) Dynamic Monitor Forecast
10.4 Europe Minimal Residual Disease (MRD) Dynamic Monitor Forecast by Country (2026-2031)
10.4.1 Germany 麻豆原创 Minimal Residual Disease (MRD) Dynamic Monitor Forecast
10.4.2 France 麻豆原创 Minimal Residual Disease (MRD) Dynamic Monitor Forecast
10.4.3 UK 麻豆原创 Minimal Residual Disease (MRD) Dynamic Monitor Forecast
10.4.4 Italy 麻豆原创 Minimal Residual Disease (MRD) Dynamic Monitor Forecast
10.4.5 Russia 麻豆原创 Minimal Residual Disease (MRD) Dynamic Monitor Forecast
10.5 Middle East & Africa Minimal Residual Disease (MRD) Dynamic Monitor Forecast by Region (2026-2031)
10.5.1 Egypt 麻豆原创 Minimal Residual Disease (MRD) Dynamic Monitor Forecast
10.5.2 South Africa 麻豆原创 Minimal Residual Disease (MRD) Dynamic Monitor Forecast
10.5.3 Israel 麻豆原创 Minimal Residual Disease (MRD) Dynamic Monitor Forecast
10.5.4 Turkey 麻豆原创 Minimal Residual Disease (MRD) Dynamic Monitor Forecast
10.6 Global Minimal Residual Disease (MRD) Dynamic Monitor Forecast by Type (2026-2031)
10.7 Global Minimal Residual Disease (MRD) Dynamic Monitor Forecast by Application (2026-2031)
10.7.1 GCC Countries 麻豆原创 Minimal Residual Disease (MRD) Dynamic Monitor Forecast
11 Key Players Analysis
11.1 BGI Genomics Co.,Ltd.
11.1.1 BGI Genomics Co.,Ltd. Company Information
11.1.2 BGI Genomics Co.,Ltd. Minimal Residual Disease (MRD) Dynamic Monitor Product Offered
11.1.3 BGI Genomics Co.,Ltd. Minimal Residual Disease (MRD) Dynamic Monitor Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.1.4 BGI Genomics Co.,Ltd. Main Business Overview
11.1.5 BGI Genomics Co.,Ltd. Latest Developments
11.2 OrigiMed
11.2.1 OrigiMed Company Information
11.2.2 OrigiMed Minimal Residual Disease (MRD) Dynamic Monitor Product Offered
11.2.3 OrigiMed Minimal Residual Disease (MRD) Dynamic Monitor Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.2.4 OrigiMed Main Business Overview
11.2.5 OrigiMed Latest Developments
11.3 Burning Rock Biotech
11.3.1 Burning Rock Biotech Company Information
11.3.2 Burning Rock Biotech Minimal Residual Disease (MRD) Dynamic Monitor Product Offered
11.3.3 Burning Rock Biotech Minimal Residual Disease (MRD) Dynamic Monitor Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.3.4 Burning Rock Biotech Main Business Overview
11.3.5 Burning Rock Biotech Latest Developments
11.4 Predicine
11.4.1 Predicine Company Information
11.4.2 Predicine Minimal Residual Disease (MRD) Dynamic Monitor Product Offered
11.4.3 Predicine Minimal Residual Disease (MRD) Dynamic Monitor Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.4.4 Predicine Main Business Overview
11.4.5 Predicine Latest Developments
11.5 Genecast
11.5.1 Genecast Company Information
11.5.2 Genecast Minimal Residual Disease (MRD) Dynamic Monitor Product Offered
11.5.3 Genecast Minimal Residual Disease (MRD) Dynamic Monitor Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.5.4 Genecast Main Business Overview
11.5.5 Genecast Latest Developments
11.6 3D Medicines
11.6.1 3D Medicines Company Information
11.6.2 3D Medicines Minimal Residual Disease (MRD) Dynamic Monitor Product Offered
11.6.3 3D Medicines Minimal Residual Disease (MRD) Dynamic Monitor Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.6.4 3D Medicines Main Business Overview
11.6.5 3D Medicines Latest Developments
11.7 Gene+
11.7.1 Gene+ Company Information
11.7.2 Gene+ Minimal Residual Disease (MRD) Dynamic Monitor Product Offered
11.7.3 Gene+ Minimal Residual Disease (MRD) Dynamic Monitor Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.7.4 Gene+ Main Business Overview
11.7.5 Gene+ Latest Developments
11.8 Geneseeq
11.8.1 Geneseeq Company Information
11.8.2 Geneseeq Minimal Residual Disease (MRD) Dynamic Monitor Product Offered
11.8.3 Geneseeq Minimal Residual Disease (MRD) Dynamic Monitor Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.8.4 Geneseeq Main Business Overview
11.8.5 Geneseeq Latest Developments
11.9 Tongshu Biotechnology
11.9.1 Tongshu Biotechnology Company Information
11.9.2 Tongshu Biotechnology Minimal Residual Disease (MRD) Dynamic Monitor Product Offered
11.9.3 Tongshu Biotechnology Minimal Residual Disease (MRD) Dynamic Monitor Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.9.4 Tongshu Biotechnology Main Business Overview
11.9.5 Tongshu Biotechnology Latest Developments
11.10 Berry Oncology
11.10.1 Berry Oncology Company Information
11.10.2 Berry Oncology Minimal Residual Disease (MRD) Dynamic Monitor Product Offered
11.10.3 Berry Oncology Minimal Residual Disease (MRD) Dynamic Monitor Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.10.4 Berry Oncology Main Business Overview
11.10.5 Berry Oncology Latest Developments
12 Research Findings and Conclusion
听
听
*If Applicable.
